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Malaria-induced sepsis is associated with an intense proinflamma-
tory cytokinemia for which the underlying mechanisms are poorly
understood. It has been demonstrated that experimental infection
of humans with Plasmodium falciparum primes Toll-like receptor
(TLR)-mediated proinflammatory responses. Nevertheless, the rel-
evance of this phenomenon during natural infection and, more
importantly, the mechanisms by which malaria mediates TLR hy-
perresponsiveness are unclear. Here we show that TLR responses
are boosted in febrile patients during natural infection with P.
falciparum. Microarray analyses demonstrated that an extraordi-
nary percentage of the up-regulated genes, including genes in-
volving TLR signaling, had sites for IFN-inducible transcription
factors. To further define the mechanism involved in malaria-
mediated ‘‘priming,’’ we infected mice with Plasmodium chabaudi.
The human data were remarkably predictive of what we observed
in the rodent malaria model. Malaria-induced priming of TLR
responses correlated with increased expression of TLR mRNA in a
TLR9-, MyD88-, and IFN-dependent manner. Acutely infected WT
mice were highly susceptible to LPS-induced lethality while
TLR9/, IL12/ and to a greater extent, IFN/ mice were
protected. Our data provide unprecedented evidence that TLR9
and MyD88 are essential to initiate IL12 and IFN responses and
favor host hyperresponsiveness to TLR agonists resulting in
overproduction of proinflammatory cytokines and the sepsis-like
symptoms of acute malaria.
Malaria constitutes the most devastating global health problemin human history. The pathogenesis of malaria is multifac-
torial. Serious sequelae can result from 3 primary pathophysiolog-
ical events: (i) red blood cell destruction; (ii) adhesion of infected
erythrocytes to the capillary veins, especially in the CNS; and (iii)
an excessive proinflammatory response. The latter is responsible for
symptoms such as rigors, headache, chills, spiking fever, sweating,
vasodilatation, and hypoglycemia (1, 2). The initial proinflamma-
tory response during malaria appears to play a critical role in the
development of cerebral malaria (3), anemia (4), and thus, death.
Toll-like receptors (TLRs) are receptors of the innate immune
system that recognize a variety of microbial products such as LPS
from Gram-negative bacteria (5). More recently, it was shown that
TLRs also recognize molecules derived from protozoan parasites,
including Plasmodium (6–10). Indeed, there is a growing body of
literature that TLRs are central mediators of proinflammatory
responses during malaria (11). For example, mice deficient in
MyD88, an essential adapter molecule for all of the TLRs except
TLR3, displayed impaired synthesis of proinflammatory cytokines
and commensurate attenuation of symptoms when infected with
different Plasmodium strains (12–14).
Despite concerted effort, a consensus on which malarial mole-
cule is responsible for activating cytokine production in immune
cells has not been achieved. Two candidates have been proposed:
malarial glycosylphosphatidylinositol (GPI) anchors and parasite-
derivedDNAbound to hemozoin. These putative ‘‘malarial toxins’’
have been shown to activate TLR2 and TLR9, respectively (8, 10).
As human polymorphisms that affect the outcome of malaria have
been described for TLR2, TLR9 (15, 16), andMAL/TIRAP (17), it
seems likely that TLRs are involved in innate immune responses to
malaria and possible that TLRs 2 and 9 are the main receptors
involved.
One approach to define a role for a specific TLR in disease is to
examine affected patients for the development of tolerance through
a defined signal transduction pathway. LPS-challenged humans, for
example, are hyporesponsive to LPS-mediated responses when
subsequently re-challenged (18). Cells from patients with Gram-
negative bacterial septicemia are similarly hyporesponsive to LPS
(19), indicating that the TLR4 pathway has entered into a state of
innate immune ‘‘tolerance’’ (20). Tolerance almost certainly exists
in malaria, as patients from areas where reinfection occurs almost
daily often do not exhibit the signs and symptoms of disease despite
the presence of blood parasites (21, 22).
McCall et al. studied TLR function in peripheral blood mono-
nuclear cells (PBMC) from individuals experimentally infected
with malaria (23). Their results suggested that as a result of malaria
infection, the innate immune response was enhanced to TLR1/
TLR2 and TLR4 agonists. This finding wasmost surprising because
it is markedly dissimilar to numerous reports of immune hypore-
sponsiveness (often referred to as ‘‘immune paralysis’’) during
bacterial sepsis even though this syndrome, in many respects,
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mimicsmalaria.However, due to the nature of human experimental
infection, subjects in this study were minimally symptomatic with
very low parasitemia. This suggested to us that the effects they
described were confined to the very earliest stages of malaria
infection and that tolerance had not yet developed at the time that
patient blood was collected for study. Furthermore, no obvious
mechanism of the priming observed was delineated.
It was for this reason that we attempted to identify TLR usage
during acute natural malaria with the idea that naturally infected
patients would, in time, develop specific tolerance to the appropri-
ate TLR ligand after experiencing high levels of parasitemia for a
period of several days. In fact, we found that acute infection with
Plasmodium falciparum in humans resulted in enhanced activation
of innate immune cells to TLR agonists. This phenomenon was
reproduced inPlasmodiumchabaudiAS infectedmice andoccurred
in a TLR9/IL 12/IFN-dependent manner. The mechanism by
which malaria infection primes the innate immune responses of the
host was found to be that TLR9 activation during Plasmodium
infection initiates endogenous IL 12 and IFN production, which in
turn enhances TLR expression and ‘‘primes’’ associated signaling
pathways. Our data indicate that this augmented TLR expression
leads to a stage of hyperresponsiveness to TLR agonists, and, as
confirmed in mice, dramatically enhances the deleterious effect of
an endotoxin challenge, as might occur in humans during coinfec-
tion with Gram-negative pathogens such as Salmonella.
Results
Increased TLR Responses During Acute P. falciparum Infection. PB-
MCs were isolated from P. falciparum naturally infected subjects to
investigate TLR responses during acute malaria infection. PBMCs
obtained fromcontrol subjects living in the sameendemic areawere
analyzed in parallel (Fig. 1). With the sole exception of the TLR3
ligand, pI:C, increases in all TLR responses were observed in
PBMCs from individuals acutely infected compared to healthy
subjects (Fig. 1). Together, these results suggested that P. falcipa-
rum infection primes cells to subsequent TLR stimulation.
Chemotherapy Reverses Hyperresponsiveness of TLR Responses.
Plasma samples from subjects with acute P. falciparum infection
collected before and 3–4 weeks after curative mefloquine chemo-
therapy were used for evaluation of cytokines. P. falciparum infec-
tion led to a significant enhancement of systemic levels of proin-
flammatory cytokines.All patients reported greatly improved sense
of well being and the absence of symptoms after therapy. The
clinical characteristics of these patients are listed in Table S1.
Coincident with this clinical improvement, cytokine levels were
significantly diminished after chemotherapy (Fig. 2A). After cura-
tive chemotherapy, cytokine levels produced in response to TLR
stimulation were back to baseline levels (Fig. 2B).
TLR/IFN Pathways Are Boosted During Acute Malaria Infection. To
define the mechanism by which malaria mediates up-regulation of
proinflammatory cytokines, we profiled mRNA obtained from
infected individuals before and after curative chemotherapy. Fig.
2C and Table S2 show a panel of select genes up-regulated as a
result of P. falciparum infection. Although neither TLR3 nor TLR9
expression was dramatically altered, TLR7 expression was en-
hanced approximately 2.6-fold (P  0.01, data not shown). Statis-
tically significant changes were also observed with TLRs 1, 2, 4, and
8 (P 0.05).Genes involved inTLR signaling pathways consistently
showed changes during P. falciparum infection (Fig. 2C). Expres-
sion of CD36, a coreceptor for TLR2 associated with the recogni-
tion of malaria parasites and subsequent induction of proinflam-
matory cytokines (24), was also up-regulated. In addition, we
observed enhanced expression of various elements of IFN signaling
pathways (Table S2). An analysis of the promoters of the up-
regulated genes revealed that a large number of these genes had
sites for IFN-inducible transcription factors (Table S3). The tran-
scriptional changes of select genes in TLR or related signal trans-
duction pathways were validated by qPCR (Fig. 2D). To determine
if the up-regulation of TLR mRNA results in increased protein
expression, we assessed the surface expression of TLR2 and TLR4
by flow cytometry. Expression of TLR2 and TLR4 were signifi-
cantly augmented in CD11c/CD14 monocytes (Fig. 3 and S1).
Increased TLR Responses During Acute P. chabaudi Infection.Next, we
evaluated the response of mouse spleen cells to TLR ligands during
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Fig. 1. Hyperresponsiveness of PBMCs from symptomatic malaria patients.
ELISA analysis of cytokine levels in PBMC supernatants from uninfected health
controls (open circles) or P. falciparum acutely infected subjects (closed trian-
gles) after 20 h of stimulation with LPS (100 ng/ml), Pam2cysk4 (4 nM), Poly:IC
(100 g/ml), CL075 (100 ng/ml), and ODN 2007 (10 M). All stimulations were
performed with 2 other 10-fold different concentrations of TLR ligand, with
similar results. Significant differences are indicated with p-values using un-
paired t test with Welch correction or Mann-Whitney test when a normality
test failed.
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experimental infection with P. chabaudiAS. In this model, mice are
injected i.p. with 105 infected red blood cells (iRBCs). Although
animals exhibit signs of disease, lethal infection is uncommon. The
parasitemia course in WT mice was typical for experimental
infection with P. chabaudi (Fig. 4A) (25). Severe symptoms were
concomitant with parasitemia and the peak of cytokine production
in serum (Fig. S2). Splenic cells were harvested before and at
several weeks post infection and stimulated with TLR ligands or
malaria extracts. We observed a significant increase in IFN
production (approximately 20-fold) by splenocytes isolated from
mice during acuteP. chabaudi infection (7 days post infection)when
compared to control mice (Fig. 4B). During the following weeks,
IFN levels produced in response to TLR agonists were compa-
rable to those found in control mice, although during the second
week after infection a drop in IFN responses was observed. Taken
together, our results show that rodent malaria recapitulates the
innate immune response in human disease, leading to proinflam-
matory priming of TLR responses.
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Fig. 2. Cytokine response in symptomatic malaria patients is reversed after curative chemotherapy. (A) Levels of 6 cytokines (TNF, IL1, IL6, IL8, IL10, and
IL12p70) were determined in the plasma of P. falciparum infected subjects before treatment (closed triangles) or 30 days after treatment (open boxes) using CBA.
(B) PBMC isolated from P. falciparum infected individuals before (closed triangles) or after treatment (open boxes) were cultured in the presence of the indicated
stimuli for 20 h. Levels of TNF-, IL-1, and IL12p40 were measured in culture supernatants by ELISA. Significant differences are indicated with p-values using
paired t test or Willcoxon matched-pairs signed-ranks test when a normality test failed. (C) Results of the clusterization. Each row represents a gene and each
column the Log2 of the ratio of gene expression level: ‘‘Before treatment’’/‘‘After treatment’’ for the gene in question. (D) Validation of the results by qPCR is
shown for some of the genes in the Fig. 1C. Each row represents a gene tested and each column the log2 of the ratio of the quantity of cDNA ‘‘Before
treatment’’/‘‘After treatment’’ standardized by the 2microglobuline cDNA.
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Fig. 3. Increased expression of TLR2 and TLR4 in monocytic cells from
symptomatic malaria patients. PBMC were isolated from acute infected indi-
viduals before and 30 days after treatment and analyzed ex vivo through flow
cytometry. The expression of TLR2 and TLR4 was evaluated in CD14 and
CD11c cells. Representative histogram showing fluorescence intensity of
TLR2 in CD14 (Left) and CD11c (Right) cells.
A B
Fig. 4. Hyperresponsiveness of spleen cells from mice undergoing acute
malaria. C57BL/6 mice were challenged with 105 iRBCs and followed every 3
days for (A) parasitemia and (B) levels of IFN measured in culture supernatants
from mouse spleen cells harvested at various weeks post infection and stim-
ulated with LPS (1 g/ml), Pam3cysk4ser (1 g/ml), CpG DNA (1 g/ml), or malaria
extract (100 g/ml) for 48 h. As a control for cell viability, cells were stimulated
with the mitogen Concanavalin A (5g/ml). The levels of IFNwere measured
in culture supernatants 48 sh post stimulation. The results are averages of 5
animals from a representative out of 2 experiments that yield similar results.
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MyD88 and IFN-Dependent Up-Regulation of TLR mRNA Correlates
with P. chabaudi Mediated-Priming of TLR Responses. One explana-
tion for the enhanced response to TLR ligands during infection
would be that levels of receptor expression are increased. We
therefore evaluated the levels of TLR mRNA in spleens of WT
C57BL/6, TLR9/, MyD88/, and IFN/ mice during P.
chabaudi infection. Significant up-regulation of all of the TLRs
tested was observed in WT mice at 6 days post infection and was
clearly trending back to baseline by day 9. Up-regulation of TLR
expression was significantly diminished in TLR9/, MyD88/,
and IFN/ mice (Fig. 5A). As expected, 7 days post infection,
splenocytes fromWTmice produced large amounts of IFN while
cells from infected TLR9/ mice produced significantly lower
levels of this (Fig. 5B) and other cytokines (Fig. S3) in response to
TLR ligands.
TLR9, IL12, IFN, and T Cells Mediate Hyperresponsiveness and Sus-
ceptibility to Endotoxin Shock During Malaria. We have gained
further insights into the role of TLR9 in priming innate immune
responses duringmalaria.We show that in vitro stimulation of bone
marrow derived dendritic cells (BMDCs) with P. chabaudi iRBCs
induced IL12 production in a manner that depends on TLR9 (Fig.
S4A). To assess the mechanism and relevance of TLR hyperre-
sponsiveness during acute malaria, we infected WT, TLR9/,
IL12/, IFN/ and RAG/ mice with P. chabaudi and chal-
lenged them with LPS 7 days postinfection. WTmice produce high
levels of proinflammatory cytokines (Fig. S4) and became very
susceptible to i.v. injection of a sub lethal LPS challenge (i.e., 10g)
(Table 1). TLR2/ mice were as susceptible as WT (data not
shown) while TLR9/ mice produce significant lower levels of
proinflammatory cytokines (Fig. S4B) and become more resistant
to LPS challenge (Table 1). IL12/ mice showed impaired pro-
duction of proinflammatory cytokines (Fig. S4B) and full resistance
to low doses of LPS, while IFN/mice were completely resistant
to even higher LPS dose (i.e., 100 g) despite the fact that these
mice faced higher parasitemia (Table 1). RAG/ mice showed
intermediate resistance to low and high doses of LPS. Together,
these results show that the IL12/IFN axis is crucial for malaria
induced-priming of TLR responses and that TLR9 have an impact
on this phenomenon.
Discussion
The major findings of this study can be summarized as follows:
augmented TLR responses in patients naturally infected with P.
falciparum were associated both with cytokinemia and clinical
symptoms of malaria. The vast majority of the highly inducible
genes involved in the innate immune response, including the TLRs,
appear to be IFN inducible. We hypothesize that augmented
expression of genes in the TLR pathway favor the recognition of
Plasmodium by phagocytes. Finally, the state of being acutely
infected with malaria heightens the innate immune response to
challenge with unrelated microbial products in anMyD88-, TLR9-,
IL12-, and IFN-dependent manner.
The manner in which the innate immune system is activated in
malaria is difficult to precisely define. We are still not certain what
ligand or ligands are responsible for stimulating cytokine produc-
tion, although it is intriguing that a large number of TLR compo-
nents are regulated downstream froman IFN response.Overall, the
innate immune response to acute malaria results in an immuno-
logical state that is notably enhanced. Such a ‘‘primed’’ immune
system could be expected to prevent super infection with bacteria
or viruses andmight be crucial for host survival. On the other hand,
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Fig. 5. Over expression of TLRs during acute
rodent malaria. (A) Total RNA was isolated from
spleens of WT, TLR9/, MyD88/, and IFN/
micebeforeandafter6and9daysof infectionwith
P. chabaudi. TLRs mRNA levels were measured by
quantitative Real time PCR. The relative level of
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formed in duplicate. Arrows indicate where differ-
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Table 1. TLR9/, IL12/ IFN/ and RAG/ mice undergoing acute malaria display increased in vivo resistance to low LPS doses
Mouse Condition LPS dose g/mouse Number of dead/tested mice Mortality, % Mean parasitemia, % p value chi-square test
C57BL/6 Control 1 10 100 0/3 0/15 0/9 0 0 0 0 0 0
Infected 1 10 100 0/6 31/34 22/23 0 91 95.6 9 9 9
TLR9/ Control 10 100 0/9 0/5 0 0 0 0
Infected 10 100 10/16 8/8 62 100 12 15 P  0.00186
IL12/ Control 10 100 0/8 0/3 0 0 0 0
Infected 10 100 0/16 2/6 0 33.3 19 22 P  0.0001 P  0.0003
IFN/ Control 10 100 0/4 0/4 0 0 0 0
Infected 10 100 0/10 0/9 0 0 18 13 P  0.0001 P  0.0001
RAG/ Control 10 100 0/6 0/3 0 0 0 0
Infected 10 100 2/10 3/5 20 60 8 12 P  0.0001 P  0.0195
5792  www.pnas.orgcgidoi10.1073pnas.0809742106 Franklin et al.
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a highly deleterious hypercytokinemia would be expected to ensue
should a robust bacterial or viral invasion occur.
McCall and colleagues recently reported that adult individuals
experimentally infected with P. falciparum were primed for re-
sponses to some, but not all, TLR ligands. These authors found an
enhanced response to LPS (TLR4) and Pam3CysK4 (TLR2/TLR1)
(23). Our results are notably different because the enhanced innate
immune response was far more pronounced, and we found an
enhanced response to all TLR ligands except pI:C. Although
McCall et al. made an effort to correlate TLR2/4 expression with
the priming they observed; they did not see enhanced expression in
TLR2/4 inmonocytes. Themost likely reason for the limited degree
of priming and the lack of enhanced TLR expression was due to the
differences in the total body burden of parasites and the duration
of parasitemia. It is useful to recall that the experimental volunteers
were treated as soon as they become symptomatic and/or para-
sitemic, while our patients often did not present at ourmalaria clinic
until they had had fevers and rigors for more than a week. As the
average experimentally infected subject was aparasitemic for ap-
proximately 9 days (23), we infer that our patients were infected for
a period of no more than 2 weeks before study.
While virtually every cytokine response we tested was enhanced
in malaria-infected individuals, this was not the case for the
anti-inflammatory cytokine, IL10. IL10 levels were greatly in-
creased in the plasma of malaria patients. However, when PBMCs
from infected patients were stimulated with TLR ligands, we often
observed either no change in the IL-10 response or a suppression
of IL-10 release by PBMCs (data not shown). Therefore, it can be
concluded that the priming of cells for enhanced TLR responses is
not coordinated throughout the entire transcriptome, but specifi-
cally applies to a defined group of important proinflammatory
genes.
The in vivo consequences of malaria-induced priming appear to
be important and applicable to infection with other Plasmodium
species. Thus, P. chabaudi-infected mice had evidence of priming
and developed a lethal hypersensitivity to very small amounts of
LPS in a TLR9-, IL12-, and IFN-dependent fashion. Indeed, these
data are some of the best to date that malarial DNA recognition
might be pathophysiologically significant by engaging TLR9, as we
previously proposed (10). As IFN is not produced in abundance
by phagocytes, and is expressed in mouse lymphocytes (26), the
mechanism appears to involve cross talk between the innate and the
acquired arms of the immune system.
IFN has been shown not only to increase TLR expression but
also to prime cells to LPS responses in a number of experimental
infections (27–30) and has also been pointed as crucial to prime
macrophages to release high amounts of TNF upon LPS adminis-
tration and contribute to LPS induced septic shock (31). We (12)
and others (14) have shown that TLR9 accounts for a considerable
amount of IFN produced during malaria. Furthermore, produc-
tion of IL12, a potent IFN inducer, is diminished in BMDCs from
TLR9/ mice upon in vitro stimulation with P. chabaudi iRBCs.
Thus, it is reasonable to assume that themechanism bywhich TLR9
mediates priming of host innate responses during malaria is by
mediating parasite recognition and initiating IFNproduction. This
assumption is strongly supported by findings in the Propionibacte-
riummodel in which TLR9-mediated production of IFN and IL12
is required to induce priming (32). Thus, we believe that the initial
activation of innate immune responses is initiated by activation of
TLR9 and induction of IL12 by innate immune cells (e.g., DCs and
macrophages) resulting in production of IFN by NK and T cells
(33, 34). In turn, the produced IFN will prime host cells to
overexpress TLRs and become hyperresponsive to TLR agonists
(Fig. S4C).
One can speculate on the consequences for the human host
caused by malarial priming. The enhanced ability to respond to
microbial ligands during immune surveillance probably protects the
host from bacterial invasion. The areas of the world with the highest
incidence and prevalence of malaria also have a high incidence of
invasive bacterial infections, including Salmonella, Pneumococcus,
and Meningococcus (35). In general, the innate immune response
represents the classic ‘‘two-edged sword.’’ Priming means that the
innate immune system has an enhanced capacity to be over
activated during secondary infection and initiate the septic shock
syndrome. Coinfection with bacteria is not only common, but, as we
might have predicted from these results, patients with malaria and
bacteremia die at 3 times the frequency of individuals with malaria
alone (36). In addition to the ability of bacterial products to activate
a hyper immune response during coinfection, the likelihood that
parasite and/or endogenous TLR agonists act as second stimuli for
cells primed during malaria should not be disregarded. To begin,
different P. falciparum derived TLR agonists, such as GPI anchors
(8) and DNA bound to hemozoin (10), might activate an enhanced
innate immune response and result in unchecked inflammation.
Moreover, host endogenous ligands that are weak TLR agonists
have been described (37). Such endogenousmoleculesmight, under
the right circumstances (e.g., parasite-induced apoptosis), exacer-
bate the proinflammatory state of patients with malaria, even
though under ordinary circumstances, they lack potency. Thus, it is
our hypothesis that proinflammatory priming duringmalaria favors
activation of TLRs by components from host and/or microbial
origins and has the capability to induce injurious inflammatory
states, including cerebral malaria.
The observation that the innate immune system is primed during
febrile malaria could not have been predicted intuitively. In bac-
terial sepsis, most immune responses appear to be strongly sup-
pressed, thus leading to an immune state that is often described as
‘‘immunoparalysis’’ (38). Although immunosuppressive therapy
was once thought to be highly protective during septic shock (39)
and the use of high dose steroids was commonplace, it is now
recognized that this therapy increases mortality (40). By the time a
patient with bacterial sepsis is diagnosed, the innate immune system
is globally and profoundly immunosuppressed. Hence, additional
anti-inflammatory therapy is unlikely to alter the course of events.
Just the opposite appears to occur in acute malaria. Although
anti-inflammatory approaches to life-threatening malaria have
never been proven to be beneficial, it seems that the potential for
targeted immunosuppressive therapy should not be ignored. By
defining the innate immune response during the severest forms of
malaria, as we have done here in patients with moderate illness,
such strategies could be rationally designed and tested. Clearly, a
better understanding of the innate immune response is critical if
novel therapies are to be rationally designed.
Materials and Methods
Reagents. Unless stated elsewhere, all reagents were from Sigma-Aldrich. CL075
was obtained from Invivogen; ODN 7909 was synthesized by ALPHA DNA as
phosphorothioate-linked ODNs; Pam2cysk4 was from EMC Microcollection; CpG
ODN 2007 was from the Coley Pharmaceutical Group. LPS was repurified by
phenol chloroform extraction as described (41). MAbs to CD11c and TNF were
from BD PharMingen. MAbs to TLR2 and TLR4 were from eBiosciences. RPMI and
DMEM were from Gibco. Cytokine ELISA kits were from R&D Systems.
Subjects. The study was approved by the Ethic and Research Council of the Rene
Rachou Institute and the Brazilian Council of Ethics and Research (approval
number 10567). Patients with acute febrile P. falciparum malaria (n  57) were
seen in the outpatient malaria clinic in the Tropical Medicine Research Center in
Porto Velho, Brazil, an endemic malaria region in the Amazon basin. Informed
consent was obtained before enrollment. All patients gave a history of recent
fever and constitutional signs; none presented with severe anemia or cerebral
malaria (see Table S1). Average ages of patients and a group of controls were
29.4  12.8 and 31.2  7.36 respectively. Up to 100 cc of blood was obtained
immediately after confirmation of P. falciparum infection by a standard periph-
eral smear and 3–4 weeks after mefloquine therapy. PCR was used to confirm
infectionandcure,aswellas toruleoutcoinfectionwithP.vivax (42).Eachpatient
served as his or her own control; additional control individuals (n 16) included
noninfected subjects living in Porto Velho and malaria naïve individuals living in
Belo Horizonte, Brazil, where malaria is not endemic.
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PBMC Stimulation Assays. PBMCs were isolated from undiluted whole blood on
Ficoll-paque Plus (GE Healthcare) per the manufacturer’s recommendations. Cells
were plated into 96-well cell culture plates at a final density of 2 105 in DMEM
containing 10% FCS (Gibco) and 10 g ciprofloxacin (Cellofarm) per ml and
stimulated for 20 h as indicated.
Microarray Experiments and Data Analysis. Information on microarray exper-
iments and data analysis can be found in SI Text.
Analysis of Cell Surface Expression of TLRs. PBMCs from acutely infected patients
(n  11) were stained with combinations of the following mAbs: CD11c-FITC
(Serotec),CD14-FITC, (BDBiosciences), TLR2-PE,TLR4-PE (eBiosciences).Cellswere
gated by forward or side scatter to separate lymphocytes from monocytes and
assessed for fluorescence using CellQuest software (BD Biosciences). Data were
analyzed using Flowjo software (TreeStar).
Rodent Model of Malaria and Knockout Mice. The Plasmodium chabaudi
chabaudi AS strain was used for experimental infections. Mice were infected by
i.p. (i.p.) injection of 105 infected erythrocytes (iRBCs) and checked daily; mori-
bund animals were scored as dead and euthanized. Laboratory values that reflect
malaria-associated pathology were determined every 2–3 days throughout the
infection (25). C57BL/6 as well as RAG/ and IFN/ mice were originally
purchased from Jackson Laboratories. MyD88/, TLR2/, TLR9/were a gift of
S. Akira (Osaka University, Japan). Knockout mice were 8–12 weeks old and were
all backcrossed for at least 8 generations onto a C57BL/6 background. Mice were
bred under pathogen-free conditions in the animal house of Rene´ Rachou
Institute-Fundac¸ao Oswaldo Cruz.
Mouse Splenocyte Stimulation Assays. Cytokine measurements from stimulated
mouse splenocytes during P. chabaudi infection were performed with groups of
4 to 8 C57BL/6 mice and the corresponding number of knockout animals, as
indicated in the figure legends. Each experiment was repeated 2–3 times. Each
animal was analyzed individually. Mice were infected i.p. with 105 iRBCs. Spleens
were aseptically removed and macerated through a nylon mesh over the course
of the experimental infection. After RBC lysis, splenocytes were resuspended in
RPMI, 10% FCS (Gibco), 1% gentamicin (Schering Plough) at a density of 2.5106
cells per ml. Splenocytes were subsequently cultured in 48-well plates for 48 h in
a final volume of 500 l in the presence of TLRs ligands.
Cytokine Measurements. Except where noted, all measurements of cytokines
were performed using commercially available ELISA kits (R&D Systems). Serum
cytokines from P. falciparum infected-patients were quantified with the CBA
inflammation kit (Becton-Dickinson).
Real Time PCR Analysis (qPCR). Total RNA was isolated from mouse spleens over
the course of infection, as described. Sequences of primers are listed in Table S4.
The relative level of gene expression was determined by the comparative thresh-
old cycle (Ct) method using the formula 2Ct whereby data for each sample
were normalized to -actin mRNA levels and expressed as a fold change com-
pared with uninfected controls.
Statistical Analysis. All data were analyzed using Graphpad Instat 4.0 Software.
Cytokine measurements from human PBMCs were analyzed using two-tailed
student’s t test. Mann-Whitney testing was used for non-parametric analysis
when data did not fit a Gaussian distribution. A P value 0.05 was considered to
be statistically significant.
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